HomeCompareABT vs SWN

ABT vs SWN: Dividend Comparison 2026

ABT yields 2.36% · SWN yields 28.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABT wins by $508.7K in total portfolio value· pulled ahead in Year 4
10 years
ABT
ABT
● Live price
2.36%
Share price
$101.89
Annual div
$2.40
5Y div CAGR
63.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$533.6K
Annual income
$328,772.04
Full ABT calculator →
SWN
SWN
● Live price
28.13%
Share price
$7.11
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.9K
Annual income
$3.48
Full SWN calculator →

Portfolio growth — ABT vs SWN

📍 ABT pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodABTSWN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ABT + SWN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ABT pays
SWN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ABT
Annual income on $10K today (after 15% tax)
$200.23/yr
After 10yr DRIP, annual income (after tax)
$279,456.23/yr
SWN
Annual income on $10K today (after 15% tax)
$2,391.00/yr
After 10yr DRIP, annual income (after tax)
$2.96/yr
At 15% tax rate, ABT beats the other by $279,453.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ABT + SWN for your $10,000?

ABT: 50%SWN: 50%
100% SWN50/50100% ABT
Portfolio after 10yr
$279.3K
Annual income
$164,387.76/yr
Blended yield
58.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABT right now

ABT
Analyst Ratings
30
Buy
10
Hold
Consensus: Buy
Price Target
$137.67
+35.1% upside vs current
Range: $120.00 — $158.00
Altman Z
4.9
Piotroski
6/9
SWN
Analyst Ratings
23
Buy
32
Hold
5
Sell
Consensus: Hold
Price Target
$8.39
+18.0% upside vs current
Range: $5.00 — $13.00
Altman Z
-0.4
Piotroski
3/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ABT buys
5
SWN buys
0
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$ABT▼ Sell$1,001 - $15,0002026-02-10
Thomas H. Kean🏢 House$ABT▲ Buy$1,001 - $15,0002026-01-29
Gilbert Cisneros🏢 House$ABT▼ Sell$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$ABT▼ Sell$1,001 - $15,0002025-12-18
Julia Letlow🏢 House$ABT▼ Sell$1,001 - $15,0002025-12-08
Byron Donalds🏢 House$ABT▼ Sell$1,001 - $15,0002025-12-04
Byron Donalds🏢 House$ABT▼ Sell$1,001 - $15,0002025-12-04
Gilbert Cisneros🏢 House$ABT▲ Buy$1,001 - $15,0002025-11-18
Julie Johnson🏢 House$ABT▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$ABT▲ Buy$1,001 - $15,0002025-11-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricABTSWN
Forward yield2.36%28.13%
Annual dividend / share$2.40$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR63.2%-50%
Portfolio after 10y$533.6K$24.9K
Annual income after 10y$328,772.04$3.48
Total dividends collected$492.4K$3.1K
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusBuyHold
Analyst price target$137.67$8.39

Year-by-year: ABT vs SWN ($10,000, DRIP)

YearABT PortfolioABT Income/yrSWN PortfolioSWN Income/yrGap
1$11,084$384.43$12,106$1,406.47$1.0KSWN
2$12,510$649.94$13,750$795.67$1.2KSWN
3$14,505$1,118.82$15,134$422.27$629.00SWN
4← crossover$17,499$1,978.53$16,411$217.20+$1.1KABT
5$22,364$3,640.59$17,670$110.05+$4.7KABT
6$31,026$7,096.70$18,962$55.37+$12.1KABT
7$48,215$15,016.56$20,317$27.77+$27.9KABT
8$87,182$35,592.30$21,753$13.90+$65.4KABT
9$191,446$98,161.15$23,283$6.96+$168.2KABT
10$533,619$328,772.04$24,916$3.48+$508.7KABT

ABT vs SWN: Complete Analysis 2026

ABTHealthcare

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Full ABT Calculator →

SWNEnergy

Southwestern Energy Company, an independent energy company, engages in the exploration, development, and production of natural gas, oil, and natural gas liquids (NGLs) in the United States. It operates through two segments, Exploration and Production, and Marketing. The company focuses on the development of unconventional natural gas and oil reservoirs located in Pennsylvania, West Virginia, Ohio, and Louisiana. As of December 31, 2021, it had approximately 768,050 net acres in Appalachia; a total of 1,527 wells on production; and approximately proved natural gas, oil, and NGLs reserves comprise 21,148 billion cubic feet of natural gas equivalent (Bcfe). It also engages in the marketing and transportation of natural gas, oil, and NGLs. The company serves LNG exporters, energy companies, utilities, and industrial purchasers of natural gas. Southwestern Energy Company was incorporated in 1929 and is headquartered in Spring, Texas.

Full SWN Calculator →
📬

Get this ABT vs SWN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ABT vs SCHDABT vs JEPIABT vs OABT vs KOABT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.